Aceto Gabriella, Penza Rosa, Coccioli Maria Susanna, Palumbo Fabrizio, Cresta Lorenzo, Cimador Marcello, Chiozza Maria Laura, Caione Paolo
Department of Biomedicina Età Evolutiva, University, Bari, Italy.
J Urol. 2003 Oct;170(4 Pt 2):1670-3. doi: 10.1097/01.ju.0000091221.55082.17.
Desmopressin may not be effective for nocturnal enuresis associated with polyuria and hypercalciuria. Nighttime hypercalciuria in an enuretic population from 5 centers and its correlation with nighttime polyuria were verified.
A total of 450 enuretic patients (278 males, 172 females, mean age 9.7 years) were evaluated with 72-hour micturition charts, urinalysis, serum creatinine and osmolarity, diurnal and nocturnal electrolytes with fractional Na+ and K+ urinary excretion, and nocturnal (4 a.m.) plasma vasopressin. Creatinine electrolytes and osmolarity were measured in daytime (8 a.m. to 8 p.m.) and nighttime (8 p.m. to 8 a.m.) urine volumes. Patients were divided into group 1 with nocturnal polyuria and group 2 without nocturnal polyuria. Hypercalciuria was defined as urinary calcium-to-urinary creatinine ratio greater than 0.21. Statistic evaluation was performed using chi-square, Pearson correlation and ANOVA tests.
Nighttime polyuria was demonstrated in 292 bedwetters (65% group 1). Nocturnal hypercalciuria was present in 179 of the 450 children (39.7%), including 125 in group 1 (42.8%) and 54 in group 2 (34.2%), which was statistically significant (chi-square p = 0.008, Pearson correlation test r = 0.157). Daytime calciuria was not statistically modified in either group (group 1 p = 0.054, group 2 p = 0.56). Adrenocorticotropic hormone (ADH) was normal in 18.5% and low in 81.5% of enuretics with nocturnal hypercalciuria. ADH levels and nocturnal hypercalciuria significantly correlated (p = 0.003, r = 0.148). Conversely, the group 2 patients had normal ADH levels.
Nocturnal hypercalciuria has a pivotal role in nocturnal enuresis, as it is significantly associated with low ADH levels and nocturnal polyuria. A new classification of nocturnal enuresis subtypes based on nighttime calciuria levels is mandatory to address treatment properly.
去氨加压素可能对与多尿和高钙尿症相关的夜间遗尿无效。对来自5个中心的遗尿人群中的夜间高钙尿症及其与夜间多尿的相关性进行了验证。
共对450例遗尿患者(男278例,女172例,平均年龄9.7岁)进行了评估,采用72小时排尿图表、尿液分析、血清肌酐和渗透压、昼夜电解质及尿钠和钾排泄分数,以及夜间(凌晨4点)血浆血管加压素。在白天(上午8点至晚上8点)和夜间(晚上8点至上午8点)尿量中测量肌酐、电解质和渗透压。患者分为夜间多尿组(第1组)和无夜间多尿组(第2组)。高钙尿症定义为尿钙与尿肌酐比值大于0.21。采用卡方检验、Pearson相关性检验和方差分析进行统计学评估。
292例尿床患者(第1组占65%)存在夜间多尿。450名儿童中有179名(39.7%)存在夜间高钙尿症,其中第1组125名(42.8%),第2组54名(34.2%),差异有统计学意义(卡方检验p = 0.008,Pearson相关性检验r = 0.157)。两组白天的钙尿症在统计学上均无变化(第1组p = 0.054,第2组p = 0.56)。夜间高钙尿症的遗尿患者中,18.5%的促肾上腺皮质激素(ADH)正常,81.5%的ADH水平低。ADH水平与夜间高钙尿症显著相关(p = 0.003,r = 0.148)。相反,第2组患者的ADH水平正常。
夜间高钙尿症在夜间遗尿中起关键作用,因为它与低ADH水平和夜间多尿显著相关。基于夜间钙尿症水平对夜间遗尿亚型进行新的分类对于正确治疗至关重要。